Medical News Today: Added to chemotherapy, this drug doubles lung cancer survival

Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Lung Cancer Source Type: news